Kvk tech inc | Radio Compass News

KVK Tech`s Lomaira Completes Registration In Mexico

31 Jul 2024 //

PR NEWSWIRE

Enforcement Report - Week of October 25, 2023

25 Oct 2023 //

FDA

KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged

03 Oct 2023 //

FDA

KVK-Tech Issues Voluntary Nationwide Recall of one lot of Betaxolol Tablets

29 Sep 2023 //

PR NEWSWIRE

Enforcement Report - Week of September 1, 2021

01 Sep 2021 //

FDA

KVK Tech Inc., Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension

07 Aug 2021 //

FDA

KVK is excited to announce the appointment of Rahul Sareen

23 Jun 2021 //

PRNEWSWIRE

KVK-Tech, Inc. Receives FDA Warning Letter

28 Oct 2020 //

FDA

KVK-Tech, Inc Receives FDA Warning Letter

26 Feb 2020 //

FDA

Enforcement Report - Week of October 23, 2019

24 Oct 2019 //

FDA

Enforcement Report - Week of December 26, 2018

26 Dec 2018 //

FDA

Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. KVK-Tech

02 Oct 2018 //

PATENT LITIGATION

Enforcement Report - Week of August 23, 2017

23 Aug 2017 //

FDA

Oxycontin® (Oxycodone Hcl); Purdue Pharma L.PThe P.F. Laboratories & Rhodes V. Abhai And Kvk-Tech

20 Apr 2017 //